August 12, 2014 modus health, llc Names Scientific Advisory Board Members

Washington, D.C. August 12, 2014 – a digital health company focused on providing accurate and actionable physical activity data and analytics to inform clinical decision making, improve efficiency for payors, and optimize outcomes for patients, announced today the formation of its Scientific Advisory Board (SAB) with four key appointments: Thomas George Hornby, PhD, PT, Andrew Gardner, Ph.D., Lee Dibble, Ph.D., PT, ATC, and George Fulk, Ph.D., PT.

The SAB will work closely with the modus management team as it focuses on applying its FDA cleared StepWatch™ activity monitoring and modus outcomes system to address highly prevalent and costly patient care segments. These include neurological conditions, such as stroke, and Chronic Obstructive Pulmonary Disease (COPD).

“We are please to have attracted some of the nation’s leading experts in the science and clinical application of physical activity data and assessment,” commented Teri Chou, Ph.D., Director of Clinical Research at modus health. “The formation of our SAB will provide modus with invaluable input and guidance from respected leaders who are on the front lines of scientific innovation using our StepWatch™ activity monitor to better understand and improve clinical outcomes.”

Thomas George Hornby, PhD, PT, Rehabilitation Institute of Chicago

Dr. Hornby received his doctoral degree in Physiological Sciences from the University of Arizona. He is a Research Assistant Professor at Northwestern University and Director of the Locomotor Recovery Laboratory at the Rehabilitation Institute of Chicago. Dr. Hornby’s primary interests include improving locomotor function in individuals who have experienced motor impairments due to stroke or spinal cord injury (SCI). His research is integrative in that he focuses on new discoveries and on translation of these findings into rehabilitative protocols that can be implemented in the clinic. Past work has investigated the mechanisms underlying behavioral changes due to the use of robotics, body-weight-supported treadmill training, and pharmacologic agents, as well as their clinical efficacy. Current research activities include looking at the acute and chronic effects of intensive locomotor training on endogenous neurotrophins that promote synaptic connectivity; electrophysiological studies of neural mechanisms underlying volitional force generation; pharmacological studies of various drugs and their effects on motor control; and interventional studies that employ task variability and high intensity training in order to maximize recovery of stepping activity in neurologically impaired individuals.

Andrew Gardner, PhD, University of Oklahoma

Dr. Gardner received his doctoral degree in Exercise Science from Arizona State University in 1990. Currently, Dr. Gardner is a Professor within the College of Medicine/Department of Geriatrics and the Donald W. Reynolds Chair of Aging Research at the University of Oklahoma. As an exercise physiologist with expertise in exercise rehabilitation and physiology related peripheral artery disease (PAD) and

aging, Dr. Gardner has published high-impact studies that have focused on: (1) validating a treadmill exercise protocol to assess primary outcome measures used in many clinical trials world-wide, (2) randomized controlled clinical trials demonstrating the efficacy of supervised exercise programs to improve ambulatory function in patients with PAD and intermittent claudication, and (3) a recent randomized controlled clinical trial demonstrating the efficacy of a home-based exercise program to treat intermittent claudication. In addition to his interest in PAD, Dr. Gardner studies the effects of co-morbid conditions and cardiovascular risk factors, such as metabolic syndrome, age and smoking on vascular function, physical activity and function and metabolic function in older adults. This work has led to more than 135 peer-reviewed clinical research publications. Additional collaborations include clinical and translational studies in patients with vascular-mediated dementia and cognitive impairment. Finally, the roles of vascular function, oxidative stress and inflammation with muscle function, gait, balance, and falls in older adults are a developing clinical and translational research approach that merges clinical faculty in the Department of Geriatric Medicine with basic scientists within the department.

Lee Dibble, PhD, PT, ATC University of Utah

Dr. Dibble received is master’s degree in physical therapy from Duke University in 1991 and his doctoral degree in exercise and sport science from the University of Utah in 2001. He is currently an Associate Professor within the Department of Physical Therapy from the University of Utah, Director of Parkinsonism Exercise Program, and Co-director of the motion analysis core facility. Dr. Dibble’s research focuses on the effect of Parkinson disease on postural control and falls as well as the effect of exercise countermeasures as a means of minimizing these deficits. Through his participation as PI or co-investigator on previous and current grants, Dr. Dibble has developed the expertise in cross sectional studies, implementation of clinical trials of rehabilitative interventions, and longitudinal studies of the progression of disability. Dr. Dibble’s three long- term objectives are: 1) Characterize the benefits of exercise in neurodegenerative diseases in terms of central nervous system effect and alteration of the trajectory of disability. 2) Understand anticipatory and reactive postural control deficits in persons with neurodegenerative diseases. 3) Explore treatments targeted at augmenting sensory input, normalizing sensory integration, and improving motor output during postural reactions.

George Fulk, PhD, PT, Clarkson University

Dr. Fulk received his master’s degree in physical therapy from the University of Massachusetts and his doctoral degree in physical therapy from Nova Southeastern University in 2005. Dr. Fulk’s research projects have primarily focused on measuring and improving locomotor capability in people with stroke. Specifically, his research has looked at methods of measuring walking ability and overall participation in people with stroke, interventions to improve walking ability in people with stroke and other neurological conditions, and the development and use of rehabilitation engineering technologies to enhance recovery in people with neurological disorders. He has collaborated with engineering faculty to develop novel technologies that monitor walking activity and ambulatory assistive devices.

About modus health

modus health’s mission is to provide accurate and actionable physical activity data and analytics to inform clinical decision making, improve efficiency for payors, and optimize outcomes for patients. We focus on patient segments with slow or irregular gait, in which our StepWatch™ technology is uniquely accurate in measuring physical activity. For more information visit modushealth.com